{"slideshow_credits": null, "snippet": "The health care giant reported earnings of $3.8 billion in the second quarter, aided in part by the sale of the company\u2019s stake in Elan of Ireland.", "abstract": "Johnson & Johnson reports second-quarter profit of $3.8 billion, or $1.33 a share, more than doubling $1.41 billion, or 50 cents a share, during year-ago quarter; revenue rose 8.5 percent to $17.9 billion.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/07/17/business/johnson-johnson-profit-rises-on-strong-prescription-sales.html", "lead_paragraph": "The health care giant reported earnings of $3.8 billion in the second quarter, aided in part by the sale of the company\u2019s stake in Elan of Ireland.", "headline": {"main": "Johnson & Johnson Profit Rises on Strong Prescription Sales", "print_headline": "Strong Sales Underpin Earnings At J.&J."}, "_id": "51e5c7c07e0d9c0839d30236", "word_count": "252", "multimedia": [], "pub_date": "2013-07-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Elan Corporation PLC", "name": "organizations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}